Scenario projections of congenital syphilis incidence in California, 2025–2030
Preprint
Abstract
Background: In 2022, the yearly rate of congenital syphilis (CS) cases in California reached its highest point since 1950. We explored how different prevention strategies in California could impact future CS case incidence. Methods: Scenario modeling was used to project CS incidence from 2025 through 2030 based on 2015–2024 surveillance data. We compared a baseline scenario with scenarios that modeled 1) changes in the rate of annual female syphilis cases; and 2) changes in the proportion of pregnant persons adequately treated for syphilis. We then used 2016–2023 hospitalization discharge data from California to estimate charges associated with treatment of a CS case. Results: A 5–50% reduction in the absolute rate of female syphilis cases led to a 3–30% decrease in cumulative CS cases during the projection period. Increasing the proportion of pregnant persons adequately treated for syphilis by 5–50% led to a 2–23% decrease; combining both scenarios resulted in a 4–45% reduction. In the baseline scenario, projected CS treatment-associated hospitalization charges were estimated to total $399 million. A 45% reduction in CS cases resulting from the combined interventions would reduce charges by $158 million. Discussion: Female syphilis incidence and adequate treatment during pregnancy have substantial impact on CS case incidence and associated charges. California has implemented universal syphilis screening guidelines for all people aged 15–49 years alongside interventions supporting testing and treatment of pregnant persons. Continued implementation of these interventions will result in considerable savings around CS treatment and reduced need for management of long-term sequelae.Keywords
This publication has 22 references indexed in Scilit:
- Optimizing the National Response to the Syphilis and Congenital Syphilis SyndemicJAMA, 2025
- Doxycycline Postexposure Prophylaxis and Sexually Transmitted Infection TrendsJAMA Internal Medicine, 2025
- Congenital Syphilis in Live BirthsObstetrics & Gynecology, 2024
- Scenario design for infectious disease projections: Integrating concepts from decision analysis and experimental designEpidemics, 2024
- Comparing 7-Day Versus 6–8-Day Penicillin Treatment Intervals Among Pregnant People With Syphilis of Late or Unknown Duration: No Difference Found in Incidence of Congenital SyphilisOpen Forum Infectious Diseases, 2023
- Estimation of the Lifetime Quality-Adjusted Life Years (QALYs) Lost Due to Syphilis Acquired in the United States in 2018Clinical Infectious Diseases, 2022
- Incidence Trends, Risk Factors, Mortality and Healthcare Utilization in Congenital Syphilis-related Hospitalizations in the United StatesThe Pediatric Infectious Disease Journal, 2019
- Characteristics Associated With Delivery of an Infant With Congenital Syphilis and Missed Opportunities for Prevention—California, 2012 to 2014Sexually Transmitted Diseases, 2018
- Chronic lymphocytic leukaemiaNature Reviews Disease Primers, 2017
- Prediction of the Spread of Influenza Epidemics by the Method of AnaloguesAmerican Journal of Epidemiology, 2003